Your session is about to expire
← Back to Search
PEGPH20 + Chemotherapy for Pancreatic Cancer
Study Summary
This triallooks at side effects & best dose of a drug to make chemo work better for pancreatic cancer that has spread.
- Pancreatic Cancer Metastatic
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 128 Patients • NCT01588990Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What conditions can Leucovorin bolster amelioration for?
"Leucovorin is a widely used remedy for macrocytic anemia, but can also be employed in the treatment of rehydration, bladder cancer and malignant neoplasms."
Are enrollment opportunities available for this clinical trial at present?
"According to clinicaltrials.gov, this trial is no longer actively seeking patients as the last time it was updated was on November 9th 2022. Despite that fact, there are presently 1463 other medical trials in search of participants."
How many individuals have signed up to participate in this research endeavor?
"This investigation is no longer seeking new participants. Its initial posting was on January 1st 2014, and it was last modified on November 9th 2022. Although this trial has concluded recruitment, there are currently 779 trials enrolling patients with metastatic neoplasm and 684 clinical studies recruiting volunteers for Leucovorin treatments."
Do I qualify to be a participant in this research project?
"This research requires 126 participants with a history of metastatic neoplasm aged 18-75. In particular, those being considered must not have had any prior treatment in the last 3 years that included oxaliplatin or irinotecan; no past chemotherapy for metastasis; and be without pre-existing abdominal radiation therapy. Additionally, they should display a Zubrod performance status between 0 to 1."
How many locations are currently conducting this trial?
"This medical trial is underway at 100 sites located across the country, including Detroit, Burlington and Bend. If you choose to enroll, it is encouraged that you select the nearest location available in order to reduce travel needs."
Are there any records of prior experiments involving Leucovorin?
"Presently, there are 684 ongoing investigations into Leucovorin. Of these studies, 215 have progressed to Phase 3. Most of the clinical trials take place in Guangzhou, Guangdong; however, research is being conducted at 30878 separate sites around the world."
Does the eligibility criterion for this trial encompass individuals who are of age 18 or above?
"Patients aged 18 to 75 are eligible for this clinical trial. For patients outside of that age range, there are 87 trials tailored towards minors and 1400 studies catered to seniors."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger